Vivus has received NDA approval for TA-1790 (avanafil), indicated for the treatment of erectile dysfunction (ED), in the US. VIvus will market the product under the brand name Stendra in the US. Mitsubishi Tanabe Pharma has ...
Tags: avanafil, erectile dysfunction, pharmaceutical product